July 25, 2025

PureTech Health plc (PRTC) Stock Analysis: Exploring a Potential 142% Upside in Biotechnology

Investors are taking a closer look at PureTech Health plc (NASDAQ: PRTC), a dynamic player in the biotechnology sector with a promising pipeline of therapeutic innovations...

Prothena Corporation (PRTA) Stock Analysis: Uncovering the 262% Upside Potential in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA), a pioneering force in the biotechnology sector, presents a compelling case for investors with its significant upside potential of 262.47%. Based..

Geron Corporation (GERN) Stock Analysis: Exploring a Remarkable 164.76% Potential Upside in Biotech

For investors with a keen interest in the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents a compelling case, especially with its striking potential upside of 164.76%...

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Unveiling a 162.92% Potential Upside in Mental Health Biotech

ATAI Life Sciences N.V. (NASDAQ: ATAI) stands at the forefront of the biotechnology sector, with a unique focus on developing innovative treatments for mental health disorders...

Myriad Genetics, Inc. (MYGN) Stock Analysis: A Deep Dive into the 60.46% Potential Upside for Investors

Myriad Genetics, Inc. (NASDAQ: MYGN), a pivotal player in the healthcare sector, stands at the intersection of molecular diagnostics and precision medicine. Headquartered in Salt Lake..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 36.94% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is currently a focal point for investors eyeing the healthcare sector. With a market capitalization of approximately $441.33 million, this..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 210% Upside in the Biotech Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) is capturing attention in the biotech investment arena with its compelling potential upside of 210.33%, as indicated by analyst ratings. This..

RxSight, Inc. (RXST) Stock Analysis: A Look at the 53.93% Potential Upside and Analyst Consensus

RxSight, Inc. (NASDAQ: RXST), a commercial-stage medical technology company, is making waves in the healthcare sector with its innovative approach to cataract surgery. Specializing in the..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth in a Complex Market

For investors with a keen eye on the healthcare sector, Sonida Senior Living, Inc. (SNDA) represents a compelling opportunity in the niche of senior housing. Based..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 60% Potential Upside in the Pediatric Orthopedic Sector

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, specifically within the medical devices industry, as a company focused on the unique needs of pediatric..

Opthea Limited (OPT)

⚠️ No article content returned.

..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Healthcare Innovator with 93% Upside Potential

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a dynamic player in the healthcare sector specializing in treatments for rare diseases, presents a tantalizing opportunity for investors seeking high-growth..

Celcuity Inc. (CELC) Stock Analysis: A Promising Biotech with Over 100% Potential Upside

Individual investors eyeing opportunities in the biotechnology sector may find Celcuity Inc. (NASDAQ: CELC) an intriguing prospect. This Minneapolis-based company, with a market capitalization of $532.02..

Simulations Plus, Inc. (SLP) Stock Analysis: A 93% Potential Upside Awaits Investors

Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, specifically within the health information services industry, offers an intriguing investment opportunity highlighted by a..

Day One Biopharmaceuticals (DAWN) Stock Analysis: Is a 264% Upside Within Reach?

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with its ambitious goal of transforming the treatment landscape for childhood and adult diseases through innovative..

Evolus, Inc. (EOLS) Stock Analysis: Unpacking the 144% Potential Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) stands at a fascinating intersection of opportunity and potential within the healthcare sector. Specializing in the aesthetic market, this Newport Beach-based company..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Unveiling a 170% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) stands out in the volatile biotechnology sector, capturing the attention of investors with a staggering potential upside of 170.69%. This clinical-stage..

Cronos Group Inc. (CRON) Stock Analysis: Unpacking the 27.6% Revenue Growth in a Competitive Cannabis Market

Investors eyeing opportunities in the cannabis sector should consider the recent performance and future potential of Cronos Group Inc. (NASDAQ: CRON). This Canadian-based company, with a..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth in Cancer Genomics with a 6.45% Potential Upside

Personalis, Inc. (NASDAQ: PSNL) stands at the frontier of the burgeoning cancer genomics sector, offering investors a unique opportunity to tap into a rapidly evolving market...

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Potential 263% Upside in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is making waves in the healthcare sector, focusing on the burgeoning field of mental health treatment. With a market capitalization of..

Search

Funds

July 25, 2025

Search

Funds

July 25, 2025

FTSE 100

Funds